<DOC>
	<DOCNO>NCT00377260</DOCNO>
	<brief_summary>The purpose study learn whether child ear infection ( acute otitis medium AOM ) treat antibiotic . The study compare two treatment strategy , `` watchful waiting '' treatment antibiotic , determine appropriate child AOM . About 268 child Pittsburgh , age 6-23 month , AOM enrol study . They treat either Augmentin ( antibiotic ) placebo 10 day closely follow 1 month . Parents ask write information child Patient Diary . A general physical exam , include ear exam , perform 4 time study . A mucus sample collect back child 's nose . Parents ask question phone call every visit . If child improve worsened , investigator prescribe different antibiotic know kill resistant germ .</brief_summary>
	<brief_title>Acute Otitis Media ( AOM ) Therapy Trial Young Children</brief_title>
	<detailed_description>The purpose randomize , double-masked , placebo-controlled , single-center clinical trial determine efficacy antimicrobial young child acute otitis medium ( AOM ) . The primary objective compare time resolution symptom ( initial sustain ) child receive amoxicillin-clavulanate ( 90/6.4mg/kg/day 2 divide dos 10 day ) child receive placebo ( 2 divide dos 10 day ) , compare weighted average AOM-Severity Symptoms ( AOM-SOS ) score two group day 1-7 . The secondary objective : evaluate clinical efficacy amoxicillin-clavulanate vs. placebo on-therapy visit ( Day 4-5 , least 72 hour initial dose study medication ) ; evaluate clinical efficacy amoxicillin-clavulanate vs. placebo end-of-therapy visit ( Day 10-12 ) ; compare AOM-SOS AOM-Faces scale treatment group first 7 day therapy study visit ; compare proportion child treatment group develop worsen symptom receive 72 hour study medication ; compare two treatment group regard quantity analgesic medication administer child 's parent ; compare incidence adverse event accompany two treatment regimen ; compare effect amoxicillin-clavulanate vs. placebo overall proportion child nasopharyngeal ( NP ) colonization AOM pathogens ( S. pneumoniae , H. influenzae , M. catarrhalis , S. pyogenes ) , proportion child NP colonization penicillin non-susceptible S. pneumoniae ; compare 2 treatment group regard tympanometric outcome on-therapy ( Day 4-5 ) , end-of-therapy ( Day 10-12 ) follow-up ( Day 21-25 ) visit , use algorithm permit estimation probability middle ear effusion give particular tympanographic configuration ; compare direct indirect medical cost two treatment group ; compare parental satisfaction therapy two treatment group . Participants include 268 child , age 6 23 month , diagnose acute otitis medium Western Pennsylvania . These participant recruit study Children 's Hospital Pittsburgh ( CHP ) , Pittsburgh , PA , Armstrong Pediatrics ( Children 's Community Pediatrics : affiliate CHP ) Kittanning , PA . Subjects randomize receive either amoxicillin-clavulanate placebo twice daily 10 day . Parents subject ask track symptom status , medication use ( study medication acetaminophen ) , fever diarrhea study memory aid . Study procedure include medical history , vital sign , weight , clinical information regard sign symptom infection , nasopharyngeal specimen , physical exam include tympanometry . Each child examine three additional time : 4-5 day start medicine , study day 10-12 21-25 day enrol study . During visit , study staff review child 's symptom examine child 's ear . The study staff also obtain nasopharyngeal culture order look resistant bacteria make appropriate change antibiotic treatment . Daily telephone assessment make study staff day 2 , 3 , 4 therapy make sure child get well . The study staff see child anytime parent feel child improve worsened .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>age 6 23 month receive least two dos pneumococcal conjugate vaccine ( Prevnar ) Haemophilus influenzae type B vaccine evidence acute otitis medium ( AOM ) define : 1 . Recent ( within 48 hour ) , onset sign symptom score great equal 3 AOMSOS scale . 2 . Middle ear effusion evidence least two follow : decrease absent tympanic membrane mobility pneumatic otoscopy , yellow white discoloration tympanic membrane , opacification tympanic membrane , plus 1+ bulging tympanic membrane either mark erythema otalgia , 2+ 3+ bulging tympanic membrane certain sign symptom ( e.g. , toxic appearance [ capillary refill great 3 second , systolic blood pressure le 60 mm Hg ] , otalgia period great 48 hour , spontaneous perforation tympanic membrane drainage temperature great equal 105 degree F ) ; clinical anatomical characteristic might obscure response treatment ( e.g. , tympanostomy tube [ ] place history tympanostomy tube , unrepaired repair overt submucous cleft palate , higharched palate , Down 's syndrome ) ; underlie systemic problem might obscure response infection ( e.g. , serious underlie disease [ e.g. , cystic fibrosis , neoplasm , juvenile diabetes ] ) , concomitant infection would preclude evaluation response child 's AOM study medication , know renal insufficiency ( i.e. , serum creatinine great equal 1.5 time upper limit normal age ) , know hepatic insufficiency history amoxicillinclavulanateassociated cholestatic jaundice hepatic dysfunction , history immune dysfunction , deficiency receipt immunosuppressive therapy , chronic gastrointestinal condition ( i.e. , malabsorption , inflammatory bowel disease ) , malignancy ; sensorineural hearing loss either unilateral bilateral ; comedications ( e.g. , systemic corticosteroid point enrol study , one dose systemic antimicrobial therapy within 96 , investigational drug vaccine ; hypersensitivity penicillin , amoxicillin amoxicillinclavulanate , phenylketonuria know hypersensitivity aspartame ; unable complete study protocol access telephone ; current enrollment another study previously enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>acute otitis medium , infant , child</keyword>
</DOC>